Meet our partners
Building each other up and growing together
Building each other up and growing together
Our group strives constantly to strengthen its role as a scientific innovator. Our work focuses primarily on therapeutic areas, but we are also highly active in diagnosis and consumer activities surrounding cosmetics and natural health.
NThe experienced professionals forming our Alliance Management Team are deeply committed to developing lasting, successful relationships with our partners. Relying on widely proven tools and processes, they make sure our partnerships run and grow smoothly.
We are ideally positioned to manage and develop a wide array of partnerships with a broad range of stakeholders.
- Partnerships with pharmaceutical giants like Pfize or Abbvie,
- Partnerships with biotech companies like Puma (USA) or Y-Biologics (South Korea.
- Partnerships with public or private research institutes like Oncopôle Toulouse, a cancer research center with a European focus
This versatility is what allows us to build commercial, research, and development partnerships.
This versatility is what allows us to build commercial, research, and development partnerships.
Array Biopharma 2015 – Pfizer 2019 ) Our collaboration with Pfizer is a perfect example of successful cooperation.
2018 - French startup BioSerenity and Pierre Fabre worked together on codevelopment, market access, and distribution for a connected medical device in the field of urology.
2019-2021 - Biotech company PUMA Biotechnology and Pierre Fabre joined forces to develop and internationally market a second-line treatment for breast cancer.
2020- The EspeRare Foundation Foundation and Pierre Fabre formed an alliance to develop an innovative treatment targeting XLHED, a rare form of ectodermal dysplasia, using in utero administration to correct the genetic disease before the baby is born.
Our principal partners
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
